TIDMDPH

RNS Number : 1418D

Dechra Pharmaceuticals PLC

24 April 2017

24 April 2017

Dechra(R) Pharmaceuticals PLC

(Dechra or the Company)

In accordance with article 19(1) of the Market Abuse Regulations, the Company was notified today that due to a change in personal circumstances Ian Page's total beneficial interest in the Company is now 811,308 shares, which represents 0.871% of the current issued share capital.

The reduction in his beneficial shareholding relates to shares held by his sons, Andrew, David and Michael Page, who are no longer classified as a connected person under the Market Abuse Regulations.

The Notification of Dealing Forms set out below are provided in accordance with the requirements of the EU Market Abuse Regulation.

Notification of Dealing Form

 
 1.   Details of the Person Discharging Managerial 
       Responsibility ("PDMR")/person closely 
       associated with them ("PCA") 
---  -------------------------------------------------------------- 
 a)   Name                           Ian Page 
---  -----------------------------  ------------------------------- 
 2.   Reason for the notification 
---  -------------------------------------------------------------- 
 a)   Position/status                Director 
---  -----------------------------  ------------------------------- 
 b)   Initial notification/          Initial Notification 
       amendment 
---  -----------------------------  ------------------------------- 
 3.   Details of the Issuer 
---  -------------------------------------------------------------- 
 a)   Name                           Dechra Pharmaceuticals PLC 
---  -----------------------------  ------------------------------- 
 b)   LEI code                       N/A 
---  -----------------------------  ------------------------------- 
 4.   Details of the transaction(s): section 
       to be repeated for (i) each type of instrument; 
       (ii) each type of transaction; (iii) each 
       date; and (iv) each place where transactions 
       have been conducted 
---  -------------------------------------------------------------- 
 a)   Description                    Ordinary Shares of 1 pence 
       of the financial               each 
       instrument 
 
       Identification                 ISIN: GB0009633180 
       code 
---  -----------------------------  ------------------------------- 
 b)   Nature of                      Shares held by sons, who are 
       the transaction                no longer connected people 
---  -----------------------------  ------------------------------- 
 c)   Price(s) and                   Price(s)         Volume(s) 
       volumes(s) 
                                      Nil cost         2,600 
                                      Nil cost         2,000 
                                      Nil cost         2,000 
---  -----------------------------  ---------------  -------------- 
 d)        Aggregated 
            information 
             *    Aggregate volume     6,600 
 
                                       Nil cost 
             *    Price 
---  -----------------------------  ------------------------------- 
 e)   Date of the                    2017.04.24 
       transaction 
---  -----------------------------  ------------------------------- 
 f)   Place of the                   Outside a trading venue 
       transaction 
---  -----------------------------  -------------------------------

For further information, please contact:

Suzana Cross, Company Secretary

Telephone number: 01606 814730

About Dechra

Dechra is an international specialist veterinary pharmaceuticals and related products business. Our expertise is in the development, manufacture, and sales and marketing of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products. For more information please visit: www.dechra.com

Trademarks

Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHOKQDBDBKDCQB

(END) Dow Jones Newswires

April 24, 2017 07:30 ET (11:30 GMT)

Dechra Pharmaceuticals (LSE:DPH)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Dechra Pharmaceuticals Charts.
Dechra Pharmaceuticals (LSE:DPH)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Dechra Pharmaceuticals Charts.